1. China coronavirus vaccine may be ready for public in November: Official  The Straits Times
  2. UAE reports 2 deaths, 674 new coronavirus cases | Health – Gulf News  Gulf News
  3. View Full coverage on Google News
BEIJING (REUTERS) - Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Centre for Disease Control and Prevention (CDC) said.. Read more at straitstimes.com.East Asia News -BEIJING (REUTERS) - Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with the Chinese Centre for Disease

China coronavirus vaccine may be ready for public in November: Official, East Asia News & Top Stories - The Straits Times

In August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India. As part of the expanded agreement, Serum Institute will also manufactureIn August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India. As part of the expanded agreement, Serum Institute will also manufacture

Novavax aims for 2 billion COVID-19 vaccine doses with expanded India deal

Some volunteers withdrew from J&J vaccine trial in Spain after serious side effect reported in AstraZeneca UK volunteer.Some volunteers withdrew from J&J vaccine trial in Spain after serious side effect reported in AstraZeneca UK volunteer.

After AstraZeneca, some quit J&J COVID-19 trial in Spain | News | Al Jazeera

Sarah Gilbert, professor of vaccinology at Oxford University, said no corners were being cut when it came to ensuring that a vaccine was safe.Sarah Gilbert, professor of vaccinology at Oxford University, said no corners were being cut when it came to ensuring that a vaccine was safe.

Top Oxford professor behind Covid-19 vaccine reiterates safety is 'top of the list' | Daily Mail Online

Gulf News Zero Campaign aims to raise awareness to help the country flatten the curveGulf News Zero Campaign aims to raise awareness to help the country flatten the curve

COVID-19: UAE vaccine strengthens fight against coronavirus | Editorials – Gulf News

The number of confirmed cases of the coronavirus that causes COVID-19 edged closer to 30 million on Tuesday, as a Chinese health official said a vaccine may...The number of confirmed cases of the coronavirus that causes COVID-19 edged closer to 30 million on Tuesday, as a Chinese health official said a vaccine may...

Coronavirus update: Global cases edge toward 30 million, and China says vaccine may be ready by November - MarketWatch

U.S. FDA's Hahn plans 'significant' work with AstraZeneca in COVID-19 trial inquiry

Recon: AstraZeneca resumes COVID vaccine trials in South Africa, Brazil, US study still on hold | RAPS

The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.

In Global Covid-19 Vaccine Race, Chinese Shot Receives First Foreign Approval - WSJ

Novavax, Inc. (NASDAQ: NVAX), which has a Phase 2 study underway of its coronavirus vaccine candidate NVX-CoV2373, is diligently working on partnerships to ...Novavax, Inc. (NASDAQ: NVAX), which has a Phase 2 study underway of its coronavirus vaccine candidate NVX-CoV2373, is diligently working on partnerships to boost its...

Novavax, Inc. (NASDAQ:NVAX) - Novavax Expands Coronavirus Vaccine Capacity To More Than 2B Doses In 2021 | Benzinga

Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.Our best shot at ending the pandemic is by achieving herd immunity through widespread use of a vaccine. But that won't happen unless people believe it's safe.

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will

In March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signedIn March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signed up to be the first volunteers to receive jab…

Debate rages over China's Covid-19 vaccines - Asia Times

Experts say direct delivery to the lungs may give a better immune response.Experts say direct delivery to the lungs may give a better immune response.

Coronavirus: UK to test inhaled vaccines - BBC News

The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.

Researchers trial inhaled versions of Oxford and Imperial Covid-19 vaccine candidates - world news - Hindustan Times

China's COVID-19 vaccine could be ready for public in November: expert - CGTN

The United Arab Emirates (UAE) on Monday granted emergency approval for use of a coronavirus vaccine developed in China, six weeks after human trials on the vaccine started in the country.

UAE approves urgent use of China-developed COVID-19 vaccine after test on 31,000 volunteers - Global Times

Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, surmised that if we are able to bring a safe and effective vaccine to market by the end of 2020, it will still likely be late into 2021 before we are able to do once normal things, like going to a theater and comfortably not wearing a mask. Here’s everything else you need to know this week.Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, surmised that if we are able to bring a safe and effective vaccine to market by the end of 2020, it will still likely be late into 2021 before we are able to do once normal things, like going to a theater and comfortably not wearing a mask. Here’s everything else you need to know this week.

AstraZeneca resumed its COVID-19 vaccine trials after uncovering a mysterious reaction | Popular Science

The world's biggest vaccine producer, the Serum Institute of India, has warned it will take until at least 2024 to make enough vaccines to go around.The world's biggest vaccine producer, the Serum Institute of India, has warned it will take until at least 2024 to make enough vaccines to go around.

COVID-19 vaccine won't reach everyone until 2024: Serum Institute of India - Business Insider

Two scientists break down what we know about the potential Covid-19 vaccine side effects, what we might expect, and how to deal with uncertainty.Two scientists break down what we know about the potential Covid-19 vaccine side effects, what we might expect, and how to deal with uncertainty.

Coronavirus vaccine side effects: 1,000 readers asked, scientists answered

Coronavirus deaths pass 925,000; biosafety head at Chinese CDC says vaccine progress ‘very smooth’; South Korea to secure early vaccines for 30 millionCoronavirus deaths pass 925,000; biosafety head at Chinese CDC says vaccine progress ‘very smooth’; South Korea to secure early vaccines for 30 million

Global report: Covid cases near 30m as China expects vaccine as soon as November | Coronavirus outbreak | The Guardian

The director of the Chinese CDC, Gao Fu, reportedly said that not everyone in the country will need to get vaccinated against COVID-19.The director of the Chinese CDC, Gao Fu, reportedly said that not everyone in the country will need to get vaccinated against COVID-19.

COVID-19: China prioritises frontline workers, says no need to vaccinate entire population - Republic World

Experts are urging drug companies to be more transparent about how they’re testing vaccines.Experts are urging drug companies to be more transparent about how they’re testing vaccines.

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science, Technology, Health & Fitness news & opinions from leading columnists.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Bloomberg - Are you a robot?

Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.

There Won’t Be Enough COVID Vaccines for Everybody Until 2024, Warn Vaccine Makers

Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.Even with manufacturing ramped up significantly, there won't be enough COVID vaccines available for the entire globe until the end of 2024.

There Won't Be Enough COVID Vaccines for Everybody Until 2024, Warn Vaccine Makers

Maybe the wait is worth it! Click here to see why a viable coronavirus vaccine might not come fast.Maybe the wait is worth it! Click here to see why a viable coronavirus vaccine might not come fast.

Coronavirus Vaccine - No Rest From COVID-19 Until 2024? | IE

Trials of AstraZeneca Covid-19 vaccine remain on hold until midweekTrials of AstraZeneca Covid-19 vaccine remain on hold until midweek

Coronavirus: Global infections approach 30 million

Emergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures - ZAWYA MENA EditionEmergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures

Access to this page has been denied.

Mary Kate Rylands discusses the power dynamics surrounding the search for a Covid-19 vaccine.

Power, populism and cooperation: the politicisation of vaccines | Palatinate Online

A China-developed coronavirus vaccine could be ready for the public as early as November, a Chinese official has told state television, as the global race to clear the final round of trials heats up. And on late Monday, the chief biosafety expert at the Chinese Centre for Disease Control told state broadcaster CCTV that a vaccine would be available to the general public "around November or December."

China says Covid-19 vaccine could be ready for public by November

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

News of serious side effects in one participant of AstraZeneca's Covid-19 vaccine trial led some volunteers in Johnson & Johnson's vaccine trial in Spain to drop out, its lead investigator told Reuters on TuesdayNews of serious side effects in one participant of AstraZeneca's Covid-19 vaccine trial led some volunteers in Johnson & Johnson's vaccine trial in Spain to drop out, its lead investigator told Reuters on Tuesday

Some back out of J&J Covid-19 vaccine trial in Spain after AstraZeneca scare, lead investigator says | News24

As a part of the expanded agreement, Serum Institute will also manufacture the antigen component of NVX‑CoV2373, Novavax’s Covid‑19 vaccine candidate.US-based Novavax's vaccine is in mid-stage trials after an early-stage trial showed it produced high levels of antibodies against the novel coronavirusAs a part of the expanded agreement, Serum Institute will also manufacture the antigen component of NVX‑CoV2373, Novavax’s Covid‑19 vaccine candidate.US-based Novavax's vaccine is in mid-stage trials after an early-stage trial showed it produced high levels of antibodies against the novel coronavirus

Novavax-Serum Institute to produce for 200 crore Covid-19 vaccine doses

Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial. The DCGI, however, put certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which have to be Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial. The DCGI, however, put certain conditions like taking extra care during screening, providing additional information in informed consent and close monitoring for adverse events during follow-up of the study which have to be

Serum Institute Of India Gets DCGI Nod To Resume Clinical Trial Of Oxford COVID-19 Vaccine

As millions across the nation wait for a coronavirus vaccine to be administered, the chief executive of Serum Institute of India, the world’s biggest vaccine producer, suggested that once developed, a COVID-19 vaccine may not fully reach the population until 2024. The date is because [...]As millions across the nation wait for a coronavirus vaccine to be administered, the chief [...]

Coronavirus Vaccine Won't Be Available to Everyone Until 2024, CEO of World's Biggest Producer Says

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 14, 2020.

Biopharma Update on the Novel Coronavirus: September 14 | BioSpace

Serum Institute, which is in Pune, has partnered with five international pharmaceutical companies, including AstraZeneca and Novavax, to develop a vaccine and pledged to manufacture one billion doses, out of which it has promised 50% to India.Serum Institute, which is in Pune, has partnered with five international pharmaceutical companies, including AstraZeneca and Novavax, to develop a vaccine and pledged to manufacture one billion doses, out of which it has promised 50% to India.

Coronavirus Vaccine Won’t Be Available to Everyone Before End of 2024, Says Serum Institute Chief

A coronavirus vaccine doesn't need to be administered to everyone in China right now -- only front-line workers and high-risk populations.A coronavirus vaccine doesn’t need to be administered to everyone in China right now — only front-line workers and high-risk populations, the country’s top medical official said this

China says entire population doesn’t need COVID-19 vaccine